Search Results - Poh, Weijie
- Showing 1 - 11 results of 11
-
1
-
2
Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinoma by Poh, Weijie, Wong, Winnie, Ong, Huimin, Aung, Myat Oo, Lim, Seng Gee, Chua, Boon Tin, Ho, Han Kiat
Published 2012Text -
3
-
4
DNA-intercalators Causing Rapid Re-expression of Methylated and Silenced Genes in Cancer Cells by Hossain, M. Zulfiquer, Healey, Megan A., Lee, Calvin, Poh, Weijie, Yerram, Sashidhar R., Patel, Kalpesh, Azad, Nilofer S., Herman, James G., Kern, Scott E.
Published 2013Text -
5
Poly (ADP-ribose) polymerase inhibitor CEP-8983 synergizes with bendamustine in chronic lymphocytic leukemia cells in vitro by Dilley, Robert L., Poh, Weijie, Gladstone, Douglas E., Herman, James G., Showel, Margaret M., Karp, Judith E., McDevitt, Michael A., Pratz, Keith W.
Published 2013Text -
6
HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis by Schuldenfrei, Andrew, Belton, Amy, Kowalski, Jeanne, Talbot, C Conover, Di Cello, Francescopaolo, Poh, Weijie, Tsai, Hua-Ling, Shah, Sandeep N, Huso, Tait H, Huso, David L, Resar, Linda MS
Published 2011Text -
7
A glioblastoma neurosphere line with alternative lengthening of telomeres by Heaphy, Christopher M., Schreck, Karisa C., Raabe, Eric, Mao, Xing-Gang, An, Ping, Chu, Qian, Poh, Weijie, Jiao, Yuchen, Rodriguez, Fausto J., Odia, Yazmin, Meeker, Alan K., Eberhart, Charles G.
Published 2013Text -
8
Poly(ADP-Ribose) Polymerase Inhibitor Hypersensitivity in Aggressive Myeloproliferative Neoplasms by Pratz, Keith W., Koh, Brian, Patel, Anand G., Flatten, Karen S., Poh, Weijie, Herman, James G., Dilley, Robert, Harrell, Maria I., Smith, B. Douglas, Karp, Judith E., Swisher, Elizabeth M., McDevitt, Michael A., Kaufmann, Scott H.
Published 2016Text -
9
Whole Exome Sequencing of Pancreatic Neoplasms with Acinar Differentiation by Jiao, Yuchen, Yonescu, Raluca, Offerhaus, G Johan A, Klimstra, David S, Maitra, Anirban, Eshleman, James R, Herman, James G, Poh, Weijie, Pelosof, Lorraine, Wolfgang, Christopher L., Vogelstein, Bert, Kinzler, Kenneth W, Hruban, Ralph H, Papadopoulos, Nickolas, Wood, Laura D
Published 2014Text -
10
Rare Germline Variants in ATM Are Associated with Chronic Lymphocytic Leukemia by Tiao, Grace, Improgo, Ma. Reina, Kasar, Siddha, Poh, Weijie, Kamburov, Atanas, Landau, Dan-Avi, Tausch, Eugen, Taylor-Weiner, Amaro, Cibulskis, Carrie, Bahl, Samira, Fernandes, Stacey M., Hoang, Kevin, Rheinbay, Esther, Kim, Haesook T., Bahlo, Jasmin, Robrecht, Sandra, Fischer, Kirsten, Hallek, Michael, Gabriel, Stacey, Lander, Eric S., Stilgenbauer, Stephan, Wu, Catherine J., Kiezun, Adam, Getz, Gad, Brown, Jennifer R.
Published 2017Text -
11
A phase 1 study of the PARP inhibitor veliparib in combination with temozolomide in acute myeloid leukemia by Gojo, Ivana, Beumer, Jan H., Pratz, Keith W., McDevitt, Michael A., Baer, Maria R., Blackford, Amanda L., Smith, B. Douglas, Gore, Steven D., Carraway, Hetty E., Showel, Margaret M., Levis, Mark J., Dezern, Amy E., Gladstone, Douglas E., Ji, Jiuping, Wang, Lihua, Kinders, Robert J., Pouquet, Marie, Ali-Walbi, Ismail, Rudek, Michelle A., Poh, Weijie, Herman, James, Karnitz, Larry M., Kaufmann, Scott H., Chen, Alice, Karp, Judith E.
Published 2016Text